RE: caspase-3

From: Barsky, Lora (LBarsky@chla.usc.edu)
Date: Tue Sep 07 1999 - 17:40:54 EST


Hello all,  
	I recently attended a apoptosis/cytokine workshop sponsored by
Pharmingen in July.  One of the technical application specialists said they
(Pharmingen) were gathering data to support that it was possible to run both
tests on the same sample,  one followed by the other, provided you set up
the samples a particular way.  Maybe a call to customer service, or
technical application support, would help.  Of course, this data was not
published yet.  

	Good Luck

	Lora Barsky
	Children's Hospital Los Angeles

> -----Original Message-----
> From:	Maryalice Stetler-Stevenson [SMTP:stetler@box-s.nih.gov]
> Sent:	Tuesday, September 07, 1999 6:35 AM
> To:	Cytometry Mailing List
> Subject:	Re: caspase-3
> 
> 
> We also have tried this antibody in parallel with Annexin V without
> success
> but haven't done a time course, etc to determine if there are biological
> reasons this isn't working for us. I would be interested in others
> experience with this antibody and any tricks people may have used to get
> it
> to work better.
> 
> 	Maryalice
> 
> >Dear all
> >
> >We have been using a anti-Caspase-3 rabbit polyclonal ab conjugated
> >with PE (this is supposed to bind to the active form only) by flow.
> >We've looked for caspase-3 activation in camptothecin or etoposide
> >treated Jurkatt cells (cytospins confirm apoptosis in these
> >cells) after fixation and perm, without success. This ab is from
> >Pharmingen.
> >
> >Does anyone have experience with looking for caspase-3 activation by
> >flow ? Are there other antibodies available ?
> >
> >Any comments would be much appreciated.
> >
> >Fran Gibson
> >Dept Haematology
> >St. George's Hospital Medical School
> >London
> 
> Maryalice Stetler-Stevenson
> Director Flow Cytometry Unit
> Laboratory of Pathology, NCI, NIH



This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:53:57 EST